Cite

HARVARD Citation

    Egeberg, A. et al. (2018). Safety, efficacy, and drug survival of biologics and biosimilars for moderate‐to‐severe plaque psoriasis. British journal of dermatology. p. e163. [Online]. 
  
Back to record